Otros idiomas Immunovia AB

Acciones

IMMNOV

SE0006091997

Equipo médico y tecnología avanzada

Tiempo real estimado Cboe Europe Otros sitios de cotización 14:45:09 15/12/2025			Variación 5 días	Varia. 1 de enero.
0,2580 ^SEK	-0,58 %		-7,25 %	-53,11 %

26/11	Immunovia AB, Q3 2025 Earnings Call, Nov 26, 2025
26/11	Immunovia obtiene la tarifa final de reembolso de Medicare para el test Pancreasure	RE

Otros idiomas

Change in number of shares and votes in Immunovia AB (publ)	28/11
Research update Immunovia, Q3 2025: US reimbursement in focus	27/11
Immunovia receives final Medicare payment rate for Pancreasure test	26/11
Immunovia receives final Medicare payment rate for PancreaSure™ test	26/11
Immunovia AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	26/11
Immunovia Q3 oper loss at SEK 25.5 mln	26/11
Immunovia Publishes Interim Report for July-September 2025	26/11
VERIFI Study Published in Peer-Reviewed Journal Current Oncology	24/11
Immunovia : INVITATION TO IMMUNOVIA'S Q3 PRESENTATION	20/11
INVITATION TO IMMUNOVIA’S Q3 PRESENTATION	20/11
Immunovia carries out a directed issue of shares to guarantors in connection with the completed rights issue	29/10
Immunovia's PancreaSure Study Published in Leading Journal Gastroenterology	27/10
Immunovia AB Announces Acceptance of Oral Plenary Presentation at American College of Gastroenterology 2025 Annual Scientific Meeting	27/10
PancreaSure clinical validation data to be presented at the American Gastroenterology Annual Scientific Meeting	27/10
Immunovia announces outcome of rights issue	23/10
Immunovia announces outcome of the rights issue	23/10
The last day of trading in subscription rights in Immunovia's rights issue	16/10
Immunovia : Laboratory Receives CAP Accreditation	13/10
Immunovia’s Laboratory Receives CAP Accreditation	13/10
Immunovia highlights PancreaSure presentation at Inherited Gastrointestinal Cancers Meeting	10/10
Immunovia publishes information document regarding rights issue	03/10
Bulletin from the extraordinary general meeting in Immunovia AB (publ)	29/09
Immunovia to receive about SEK 100 mln from rights issue	26/09
Research update Immunovia: PancreaSure launch in the US is underway	26/09
Immunovia announces final terms of rights issue	25/09

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Immunovia AB

Acciones

IMMNOV

SE0006091997

Equipo médico y tecnología avanzada

Otros idiomas

Filtros